Skip to content

Clinical trials

Phase 1 Lymphoma, B-Cell trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Phase: Phase 1 Country / region: Poland Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20142
20161
20212
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Affimed GmbH1
Celgene1
Institut de Recherches Internationales Servier1
Regeneron Pharmaceuticals1
Taiho Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell7
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Mantle-Cell3
Waldenstrom Macroglobulinemia3
Lymphoma, Follicular2
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, Non-Hodgkin2
Multiple Myeloma2
Hematologic Diseases1
Leukemia, B-Cell1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.